Can Intraocular Lenses Become Cloudy?

Intraocular lenses can absolutely become cloudy, and it happens through several distinct mechanisms depending on the type of lens and the circumstances after implantation. The most common form is not cloudiness of the lens itself but of the thin membrane behind it, a condition called posterior capsule opacification that develops in a significant share of patients within a few years of cataract surgery. True cloudiness within or on the lens material also occurs, from calcium deposits building up inside certain lens types to tiny fluid-filled bubbles forming in others. Each cause has a different timeline, different risk factors, and different solutions.

Posterior Capsule Opacification, the Most Common Culprit

When people say their artificial lens has become cloudy, the explanation is usually posterior capsule opacification, or PCO. During cataract surgery, the natural lens is removed but its outer envelope, the capsular bag, stays in place to hold the new intraocular lens. Residual lens cells that were left behind on the capsule can grow, multiply, and migrate across the back surface of that bag. Over time, these cells undergo a transformation, laying down collagen and forming fibrous tissue or pearl-like clusters on the posterior capsule. The result is a hazy film that sits right behind the IOL and scatters incoming light, blurring vision in a way that can feel disturbingly similar to the original cataract.¹

PCO can develop months to years after surgery. For most adults, the fix is straightforward: a quick outpatient procedure called YAG laser capsulotomy, in which a laser punches a small opening through the cloudy membrane, restoring a clear optical path. The procedure takes a few minutes, requires no incision, and generally works on the first attempt. A Cochrane review examining interventions to prevent PCO found that sharp-edged IOL designs produced somewhat better visual acuity scores than rounded-edge designs, though the difference at one year was small and likely not meaningful in everyday life. At longer follow-up, the gap widened, but the evidence was low certainty and incomplete.²

Why Lens Edge Design Matters

One of the more effective strategies against PCO is built into the lens itself. Intraocular lenses with a sharp, squared-off posterior edge create a physical barrier that discourages leftover lens cells from creeping under the optic and onto the central visual axis. Think of it like a speed bump: the abrupt edge makes it harder for cells to slide underneath. In vitro work has confirmed that a continuous 360-degree sharp edge around the entire optic plays a crucial role in blocking cell migration and preventing the fibrous growth that causes PCO.³

Not all sharp-edged lenses perform the same, though. A comparative study of three hydrophobic acrylic IOLs found that the ones with a full 360-degree enhanced posterior square edge, combined with haptic designs that pressed the optic firmly against the back capsule, showed lower PCO scores than a lens lacking that continuous barrier. The gap at the junction between the optic and the haptics (the arms holding the lens in place) turned out to be a weak spot. If the sharp edge is interrupted there, cells can sneak through and seed new growth.⁴

Calcification of Hydrophilic Acrylic Lenses

Where PCO involves the tissue surrounding the lens, calcification is cloudiness within or on the lens material itself. This problem is seen almost exclusively in hydrophilic acrylic IOLs, the soft water-absorbing lenses that make up a large share of the global market. The basic chemistry goes like this: the fluid inside the eye is naturally supersaturated with calcium and phosphate ions. In a hydrophilic lens, those ions slowly diffuse into the water-loving polymer. Once enough ions accumulate, they precipitate as calcium phosphate salts. Those tiny deposits then act as seeds for further crystal growth, producing a granular haze that can progressively worsen.⁵

Electron microscopy studies have identified the crystals as primarily hydroxyapatite, the same mineral found in bone and tooth enamel, along with a precursor phase called octacalcium phosphate. The polymer’s surface chemistry plays a direct role: hydroxyl groups on the acrylic material carry a partial negative charge that attracts positively charged calcium ions, effectively welcoming the process along.⁶

After routine, uncomplicated cataract surgery, calcification of a hydrophilic IOL is rare. The risk rises sharply, however, in eyes that have undergone additional procedures. Patients who had vitrectomy surgery with gas or air tamponade (where a gas bubble is placed inside the eye to support the retina) appear particularly vulnerable. Clinical data suggest that direct contact between the intravitreal gas and the IOL surface acts as an important trigger for secondary calcification, making the combination of a hydrophilic lens and gas tamponade a recognized risk factor.⁷

Unlike PCO, calcification cannot be fixed with a laser. The deposits are embedded in or bonded to the lens material. When the cloudiness degrades vision enough to matter, the only real option is surgically exchanging the IOL for a new one, a more involved procedure that carries its own risks of complications.

Glistenings in Hydrophobic Acrylic Lenses

Hydrophobic acrylic IOLs resist calcification, but they have their own form of internal cloudiness: glistenings. These are tiny fluid-filled pockets, typically between about 1 and 20 micrometers across, that form inside the lens polymer after it has been sitting in the watery environment of the eye. Water gets absorbed into the material at a microscopic level, collects into small vacuoles, and because those little pockets have a different refractive index than the surrounding polymer, they scatter light. On a slit-lamp exam, they look like small shiny or whitish specks throughout the lens body.⁸

The number and severity of glistenings varies enormously between different IOL models. Testing of six hydrophobic acrylic lenses found glistening counts ranging from zero to over 3,500 microvacuoles per square millimeter, with mean vacuole sizes between about 5 and 10 micrometers. The amount of stray light increased proportionally with the number of glistenings. After accelerated aging, the average stray light parameter rose substantially for affected lenses.⁹

Whether glistenings actually impair a patient’s real-world vision is a question that has generated decades of debate. Some studies measuring optical bench performance find meaningful increases in stray light, especially in lenses with dense glistening formation, while many clinicians report that patients with glistenings rarely notice a difference. Two of the four lens types tested in one optical study produced stray light levels exceeding that of a healthy young natural lens, suggesting that in extreme cases the effect is real and measurable.⁸ The broader clinical picture is that most glistenings are mild enough to be cosmetically interesting on exam but functionally harmless. Severe cases are the exception.

Less Common Causes of IOL Cloudiness

Beyond the big three of PCO, calcification, and glistenings, a handful of other processes can cloud an intraocular lens.

Inflammatory deposits can form on the lens surface in patients who develop postoperative inflammation or have a history of uveitis. These appear as gray-white or pigmented material on the front or back surface of the IOL. Among the millions of cataract surgeries performed worldwide each year, postoperative complications involving IOL surface deposits occur in fewer than one in a hundred patients.¹⁰ In some cases, aggressive anti-inflammatory treatment with steroid eye drops can clear or reduce these deposits. When inflammation is chronic or the deposits are fibrotic, however, they can be stubbornly permanent.

Silicone oil, used as a long-term tamponade in complex retinal detachment repairs, poses a specific problem for silicone IOLs. The oil has a chemical affinity for the silicone lens material and can coat its surface with a thick, droplet-covered film that cannot be removed by instruments or by flushing with viscoelastic gel. The adhesion is irreversible, and when it involves the central optic, it obscures vision severely enough to require lens exchange.¹¹ This interaction is well enough known that surgeons generally avoid implanting silicone IOLs in patients who may need silicone oil surgery in the future, and most modern cataract lenses are acrylic rather than silicone for this and other reasons.

Anterior capsule contraction, sometimes called capsule contraction syndrome, is another route to visual impairment after cataract surgery. Here, the same residual lens cells responsible for PCO proliferate on the front surface of the capsular bag, causing fibrosis and shrinkage that tightens the capsule opening like a drawstring. As the anterior capsule thickens and clouds over, and the capsule physically squeezes and tilts the IOL, the patient’s vision deteriorates. Certain conditions that affect wound healing, such as pseudoexfoliation syndrome and diabetes, increase the risk.¹²

The Pediatric Problem

In children, IOL cloudiness from PCO develops far more aggressively and frequently than in adults. Young eyes have more active lens epithelial cells, a stronger inflammatory response, and a much longer time horizon for complications to develop. Data from large trials of cataract surgery in children under two found visual axis opacification in roughly 40% of eyes that received an IOL, compared with only about 4% of eyes left without one. IOL implantation in infants was associated with more than five times the likelihood of needing a second operation.¹³

Because of this, pediatric cataract surgeons often perform a primary posterior capsulotomy at the time of the original surgery, sometimes combined with removal of a portion of the gel-like vitreous behind the lens, to preemptively clear the path before regrowth can begin. Even with these measures, re-clouding rates remain higher in children than adults, and repeated procedures across childhood are not uncommon. Whether to implant an IOL at all in very young infants, versus leaving the eye lens-free and correcting with contact lenses, remains one of the more genuinely difficult decisions in pediatric ophthalmology.

When IOL Exchange Becomes Necessary

For calcification and other forms of opacification that affect the lens material rather than the surrounding capsule, surgical IOL exchange is often the only option. This involves reopening the eye, carefully freeing the implant from any adhesions to the capsular bag, removing it, and inserting a replacement. Granular deposits that accumulate on or just below the IOL surface can cause significant deterioration in visual quality, and when that happens, exchange surgery is generally the accepted course even though it carries higher risks than the original cataract procedure.¹⁰

Advanced imaging has made it easier to distinguish between different types of IOL opacification before committing to surgery. Anterior segment optical coherence tomography can visualize the lens position, the state of the posterior capsule, and the character of deposits or haze on or within the IOL, helping surgeons decide whether a YAG capsulotomy will suffice or whether a full exchange is warranted. The ability to see fine structural detail non-invasively has become an increasingly important part of the diagnostic workup when a patient’s vision declines after cataract surgery.

Choosing a Lens Material to Minimize Risk

Given the different vulnerabilities of each lens type, material choice becomes a practical consideration. Hydrophilic acrylic IOLs are softer, easier to fold through small incisions, and generally more affordable, but they are the ones susceptible to calcification. Hydrophobic acrylic IOLs resist calcification effectively yet can develop glistenings. Silicone IOLs are mostly used in specific clinical situations now and carry the silicone oil adhesion risk.

For patients who are likely to need retinal surgery in the future, or who have conditions like diabetes that may require intraocular gas injections, avoiding hydrophilic acrylic lenses is a practical step to reduce the risk of calcification.⁷ In otherwise healthy eyes undergoing straightforward cataract surgery, the risk of calcification with a hydrophilic lens is very low, and the choice between hydrophilic and hydrophobic materials often comes down to surgeon preference, cost, and the specific optical features the lens offers.

Regardless of material, a lens with a continuous 360-degree sharp posterior edge remains one of the most reliable design features for reducing PCO, the most common form of post-surgical cloudiness.³

Drug-Eluting Lenses and Future Prevention

Researchers have been working on ways to build anti-clouding defenses directly into the lens. The concept is a drug-eluting IOL: a lens that slowly releases medication after implantation to suppress the cell growth and inflammation that lead to PCO and other forms of opacification. Several approaches are under investigation, including soaking lenses in drug solutions before implantation, coating them with polymer layers loaded with anti-inflammatory or anti-proliferative agents, and even covalently bonding drugs to the lens surface.¹⁴

One promising line of work uses a coating of the non-steroidal anti-inflammatory drug bromfenac embedded in a biodegradable polymer applied to the lens via ultrasonic spray technology. In preclinical testing, this design delivered sustained drug release aimed at preventing PCO development.¹⁵ Another approach uses a polydopamine-based coating loaded with the anti-proliferative drug doxorubicin, topped with a hydrophilic outer layer that slows drug release. In laboratory and animal studies, this multifunctional coating prevented PCO by inducing cell death in migrating lens cells while remaining biocompatible with surrounding eye tissues.¹⁶

None of these drug-eluting designs have reached widespread clinical use yet, and the leap from animal models to human eyes is substantial. But the volume of research suggests that the next generation of IOLs may arrive with built-in pharmacological defenses against the cell growth that currently makes post-cataract cloudiness so common. For now, the combination of sharp-edged lens design, careful material selection, and the availability of YAG laser capsulotomy as a reliable backup means that IOL cloudiness, while genuinely common, is almost always manageable.

1
PubMed. Posterior capsular plaque: a common feature of cataract surgery in the developing world
2
Cochrane Database of Systematic Reviews. Interventions for preventing posterior capsule opacification
3
PubMed Central. Square-edge intraocular lenses and epithelial lens cell proliferation: implications on posterior capsule opacification in an in vitro model
4
PubMed Central. A comparison of posterior capsular opacification after implantation of three different hydrophobic square edge intraocular lenses
5
Scientific Reports. Development of a standardized in vitro model to reproduce hydrophilic acrylic intraocular lens calcification
6
PubMed. Opacification of hydrophilic acrylic intraocular lens attributable to calcification: investigation on mechanism
7
PubMed Central. Clinical Characteristics of Patients with Intraocular Lens Calcification after Pars Plana Vitrectomy
8
PubMed Central. Effects of glistenings in intraocular lenses
9
PubMed. Glistening Formation and Light Scattering in Six Hydrophobic-Acrylic Intraocular Lenses
10
PubMed Central. Steroid-Responsive Intraocular Lens Deposits: A Case-Based Review of Diagnosis and Management
11
PubMed. Irreversible silicone oil adhesion to silicone intraocular lenses. A clinicopathologic analysis
12
PubMed Central. Anterior Capsular Contraction Syndrome in Cataract Surgery: A Review of Challenges and Solutions
13
Cochrane Database of Systematic Reviews. Surgical interventions for bilateral congenital cataracts in children under two years of age
14
PubMed Central. Drug-Eluting Intraocular Lenses
15
Bioactive Materials. Drug-eluting intraocular lens with sustained bromfenac release for conquering posterior capsular opacification
16
PubMed. Drug-Eluting Hydrophilic Coating Modification of Intraocular Lens via Facile Dopamine Self-Polymerization for Posterior Capsular Opacification Prevention